Trial intelligence / Profile preview

Progesterone support type and cytokine polymorphisms in risk of ovarian hyperstimulation syndrome during IVF/ICSI

2009-012666-31Phase 4Completed

Sponsor
Leeds Teaching Hospitals NHS Trust
Start
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of progesterone in ovarian hyperstimulation syndrome (OHSS) (2 arms), sponsored by Leeds Teaching Hospitals NHS Trust. Primary endpoint: Incidence of OHSS in luteal phase. Started Oct 2009; status: completed.

02

Drugs

progesterone
03

Conditions

ovarian hyperstimulation syndrome (OHSS)

Beyond the preview

Go deeper on 2009-012666-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-012666-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call